Evolution of antimicrobial resistance of Acinetobacter baumannii in a university hospital

Letters in Applied Microbiology

Volumn 53, Issue 3, 2011, Pages 374-378

  Viana, G F ^a   dos Santos Saalfeld, S M ^a   Garcia, L B ^a   Cardoso, C L ^a   Pelisson, M ^b   Tognim, Maria Cristina Bronharo ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

^b STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Acinetobacter baumannii; Epidemiology; Genotyping; Nosocomial infections; Resistance

Indexed keywords

CLONING; MICROORGANISMS;

ACINETOBACTER BAUMANNII; ACINETOBACTERS; ANTIMICROBIAL RESISTANCES; ANTIMICROBIAL SUSCEPTIBILITY; BAUMANNII; CARBAPENEMS; GENOTYPING; MOLECULAR EPIDEMIOLOGY; NOSOCOMIAL INFECTION; RESISTANCE;

HOSPITALS;

AMIKACIN; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; GATIFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; SULTAMICILLIN; TETRACYCLINE; TIGECYCLINE; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; AGAR DILUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; DISK DIFFUSION; GENOTYPE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; NONHUMAN; NOTE; POLYMERASE CHAIN REACTION; UNIVERSITY HOSPITAL;

ACINETOBACTER BAUMANNII;

EID: 80051657741     PISSN: 02668254     EISSN: 1472765X     Source Type: Journal    
DOI: 10.1111/j.1472-765X.2011.03109.x     Document Type: Note

References (18)

1. Al-Sweih, N.A., Al-Hubail, M.A. and Rotimi, V.O. (2011) Emergence of tigecycline and colistin resistance in Acinetobacter species isolated from patients in Kuwait hospitals. J Chemother 23, 13-16.
2. van Belkum, A., Tassios, P.T., Dijkshoorn, L., Haeggman, S., Cookson, B., Fry, N.K., Fussing, V., Green, J. et al. (2007) Guidelines for the validation and application of typing methods for use in bacterial epidemiology. Clin Microbiol Infect 13(Suppl 3), 1-46.
3. Clinical and Laboratory Standards Institute (2010) Performance Standards for Antimicrobial Susceptibility Testing; 20th Informational Supplement. Approved Standard M100-S20. Wayne, PA: Clinical and Laboratory Standards Institute.
4. Dijkshoorn, L., Nemec, A. and Seifert, H. (2007) An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 5, 939-951.
5. Falagas, M.E. and Karveli, E.A. (2007) The changing global epidemiology of Acinetobacter baumannii infections: a development with major public health implications. Clin Microbiol Infect 13, 117-119.
6. Gales, A.C., Jones, R.N. and Sader, H.S. (2006) Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004). Clin Microbiol Infect 12, 315-321.
7. Giamarellou, H. (2010) Multidrug-resistant Gram-negative bacteria: how to threat and for how long. Int J Microbial Agents 36(Suppl 2), S50-S54.
8. OXA-51 isolados no Hospital Universitário de Londrina. Braz J Infect Dis 12(Suppl 3), S21.
9. Higgins, P.G., Dammhayn, C., Hackel, M. and Seifert, H. (2010) Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 65, 233-238.
10. Jones, R.N., Ferraro, M., Reller, L.B., Schreckenberger, P.C., Swenson, J.M. and Sader, H.S. (2007) Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp. J Clin Microbiol 45, 227-230.
11. Karageorgopoulos, D.E. and Falagas, M.E. (2008) Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 8, 751-762.
12. Misbah, S., AbuBakar, S., Hassan, H., Hanifah, Y.A. and Yusof, M.Y. (2004) Antibiotic susceptibility and REP-PCR fingerprints of Acinetobacter spp. isolated from a hospital ten years apart. J Hosp Infect 58, 254-261.
13. Munoz-Price, L.S. and Weinstein, R.A. (2008) Acinetobacter infection. N Engl J Med 358, 1271-1281.
14. Neonakis, I.K., Spandidos, D.A. and Petinaki, E. (2011) Confronting multidrug-resistant Acinetobacter baumannii: a review. Int J Microbiol Agents 37, 102-109.
15. Peleg, A.Y., Seifert, H. and Paterson, D.L. (2008) Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21, 538-582.
16. Silbert, S., Pfaller, M.A., Hollis, R.J., Barth, A.L. and Sader, H.S. (2004) Evaluation of three molecular typing techniques for nonfermentative Gram-negative bacilli. Infect Control Hosp Epidemiol 25, 847-851.
17. Tan, T.Y., Poh, K. and Ng, S.I. (2007) Molecular typing of imipenem-resistant Acinetobacter baumannii-calcoaceticus complex in a Singapore hospital where carbapenem resistance is endemic. Infect Control Hosp Epidemiol 28, 941-944.
18. Tognim, M.C., Gales, A.C., Penteado, A.P., Silbert, S. and Sader, H.S. (2006) Dissemination of IMP-1 metallo-beta-lactamase-producing Acinetobacter species in a Brazilian teaching hospital. Infect Control Hosp Epidemiol 27, 742-747.